Biomet Hip Lawyer Site

Biomet Metal on Metal Hip Replacement and its Disadvantages

There has been an alarming growth in the number of complaints from patients who have received hip replacement surgeries because of a defective metal-on-metal hip replacement systems over that past ten years, an online source says.  An FDA review stated that metal hip replacement devices were affiliated to thousands of detrimental reports, 16,800 in total wherein 14,000 of which requiring revision procedures, an online website newson6.com reported. 

Metal on metal hip replacement devices are used to be a popular choice of some hip surgeons and doctors but the growing number of complaints received from patients prompt some manufacturers to recall some of their hip implants, specifically metal designed devices.

Biomet is one of the many medical device manufacturers which have contributed a number of new technologies into the orthopedic device industry. Among Biomet’s line of products, hip replacement devices are still the foundation of the company.However despite of the company’s success, it had its share of problematic devices namely the M2a Magnum hip implant products and the Stanmore and Exceed ABT devices, in which both are made from metal-on-metal designs. Like any other metal on metal hip replacements, Biomet’s M2a Magnum has been causing conditions such as metallosis to patients. Metallosis is a condition wherein metal components when rubbed together, it tends to release metal particles into the bloodstream that may lead to metal poisoning.

Since the August 2010 recall of DePuy Orthopaedics’ ASR hip resurfacing system and ASR Acebular system, Biomet’s hip replacement devices have been subjected to the growing safety concerns associated with the devices.Apparently, these problems has been the agenda of the two days meeting between the agency (FDA) and the Orthopaedic and Rehabilitation devices panel, specifically to examine the safety of the metal-on-metal hip implants concerning the potentiality of these devices to expose patients to dangerous levels of metallic debris.

Recently, Biomet has earned hundreds of lawsuits, asserting about the manufacturer’s early knowledge about the defects of its design, which is a claim very common to all device manufacturers which had a recall of their products for the past five years. It was reported that a medical expert once said that the answer to the problem is not recall but just a temporary obstruction to further damages; thus clinical studies should have been a mandatory requirement that needs to be performed before a device was released and not a solution of a problem that might have been prevented to exist.

Sources:

• sites.google.com/a/strykerhipreplacementrecall.com/www/2012-biomet-magnum
• biomet.com/searchResults.cfm?collection=patients&criteria=hip+replacement
• biomet.com/patients/hip_replacement.cfm